FinancialBuzz.com’s latest
The Buzz
Show: Featuring Our Corporate News Recap on “
Second Sight Medical
Receives FDA Approval
for the Argus 2s Retinal Prosthesis System
”
Second Sight Medical
(NASDAQ: EYES)
Products surged just under 60% in premarket trading after the company announced the U.S. Food and Drug Administration has approved the Argus 2s Retinal Prosthesis System.
The Company expects that the redesigned set of external hardware initially for use in combination with previously implanted Argus II systems for the treatment of retinitis pigmentosa, will be adapted to be the external system for the next generation Orion Visual Cortical Prosthesis System, currently under development.
Second Sight Medical Products, Inc. develops and markets implantable visual prosthetics that are intended to deliver useful artificial vision to blind individuals. A recognized global leader in neuromodulation devices for blindness, the Company is committed to developing new technologies to treat the broadest population of sight-impaired individuals. The Company’s headquarters are in Los Angeles, California.
For more information, please visit:
Second Sight Medical Products, Inc.
About The Buzz: A Financial Buzz Show on daily news, covering the most up to date financial information. The Buzz intends to provide factual and relevant information for its audience. The Buzz is 100% original content, created by Financial Buzz Media. Located on Wall Street in the heart of New York City’s financial district, FinancialBuzz.com is a credible source for the world’s latest trending financial and economic news. A pioneer in the financially driven digital space, video production and integration of social media, FinancialBuzz.com creates 100% unique original content.
The post
“The Buzz” Show: Second Sight Medical (NASDAQ: EYES) FDA Approval Argus 2s Retinal Prosthesis System
first appeared on
Financial Buzz
.
For further details see:
“The Buzz” Show: Second Sight Medical (NASDAQ: EYES) FDA Approval Argus 2s Retinal Prosthesis System